Home › Ductal Carcinoma In Situ (DCIS) › Kansas › Kansas City
Ductal Carcinoma In Situ (DCIS) clinical trials in Kansas City, KS
3 studies for Ductal Carcinoma In Situ (DCIS) are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
RecruitingPhase 2Healthy volunteers welcome
- University of Kansas Cancer Center, Kansas City
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RecruitingPhase 2
- University of Kansas Cancer Center, Kansas City
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RecruitingPhase 2
- University of Kansas Cancer Center, Kansas City
Ductal Carcinoma In Situ (DCIS) trials in other cities
- Houston, TX5 studies
- New York City, NY5 studies
- Chicago, IL4 studies
- Columbus, OH4 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.